Overall Technical outlook

Price Summary

On 2025-10-16, ASTRAZEN's stock opened at 9151.0, reached a peak of 9233.0, dropped to 9075.0, and ended -0.55% lower at 9101.0, with a volume of 8254 shares.
Throughout the 52-week period, the stock hit a high of 10509.5 and a low of 6305.45.

Technicals

Support and Resistance: The price currently sits at 9101.0, finding support at 8967.5 and resistance at 9340.0. These levels define a range for AstraZeneca Pharma India Limited where the price may move, with 8967.5 offering a base and 9340.0 limiting upward momentum.
ASTRAZEN supportResistance 4b1dcb
Support/Resistance for ASTRAZEN


Aroon: The AROON is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
ASTRAZEN aroon 4b1dcb
Aroon chart for AstraZeneca Pharma India Limited


Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
ASTRAZEN bbands 4b1dcb
Bolinger Bands chart for AstraZeneca Pharma India Limited


Parabolic SAR: The PSAR continues its bearish outlook, setting a key resistance level that could limit upward potential. This resistance suggests that the market may struggle to break higher, reflecting ongoing bearish pressure for ASTRAZEN.
ASTRAZEN psar 4b1dcb
Parabolic Stop and Reverse chart for AstraZeneca Pharma India Limited


Stochastic: The STOCHASTIC is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
ASTRAZEN stoch 4b1dcb
Stochastic chart for AstraZeneca Pharma India Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance for ASTRAZEN, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
ASTRAZEN trippleSMA 4b1dcb
Tripple SMA chart for AstraZeneca Pharma India Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.